THYROID NEOPLASMS
Clinical trials for THYROID NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new THYROID NEOPLASMS trials appear
Sign up with your email to follow new studies for THYROID NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive iodine: unnecessary for some thyroid cancer patients?
Disease control OngoingThis study looks at whether low-risk thyroid cancer patients need radioactive iodine treatment after having their thyroid removed. About 504 participants are randomly assigned to receive either a standard dose of radio-iodine or no radio-iodine at all. The goal is to see if skipp…
Matched conditions: THYROID NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug may prevent dangerous blood pressure spikes in thyroid surgery
Disease control OngoingThis study tests whether dexmedetomidine, a sedative, can safely control blood pressure and heart rate during surgery to remove active thyroid tumors. Eighty adults aged 20 to 65 are randomly assigned to receive either dexmedetomidine or the standard drug labetalol. The goal is t…
Matched conditions: THYROID NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: South Egypt Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill targets Hard-to-Treat cancers after other drugs fail
Disease control OngoingThis early-stage trial is testing an oral drug called LOXO-260 in about 70 people with advanced cancers that have a specific change in the RET gene. The cancers have stopped responding to other targeted treatments. The study aims to find the safest dose and see if the drug can sh…
Matched conditions: THYROID NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 26, 2026 14:08 UTC